FDA Clears Quarterable PREVICOX Tablet for Precision Canine Dosing
Image
Johns Creek, Ga. – October 07, 2026 -- Boehringer Ingelheim has secured U.S. Food and Drug Administration approval for a new Quarterable Snap-Tab design of PREVICOX (firocoxib) Chewable Tablets, enabling veterinarians to prescribe the canine pain medication to dogs as small as seven pounds.
Double-scored tablets expand dosing precision for veterinarians
The redesigned 57 mg and 227 mg tablets feature double scoring that allows division into quarters, giving veterinarians more granular, weight-based dosing options for dogs across a broader size range. PREVICOX is a COX-2 selective NSAID approved for controlling pain and inflammation from osteoarthritis and for postoperative pain following soft-tissue and orthopedic surgery in dogs.